QIAGEN – More Than Three Billion Biological Samples Tested
Brian Dugan, Senior Director, Head of Enterprise Genomics and NGS Product Management at QIAGEN discusses the more than three billion biological samples tested milestone and the more than one million samples with its next-generation sequencing (NGS) panels.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Brian Dugan, Senior Director, Head of Enterprise Genomics and NGS Product Management at QIAGEN discusses the more than three billion biological samples tested milestone and the …
- Key Point: Since joining QIAGEN, has lead commercialization of genomics solutions across application areas and modalities .
- Key Point: These developments span ultra-sensitive targeted methylation chemistry for liquid biopsy testing, single-cell RNA detection solutions, microbiology and infectious disease testin…
- Key Point: Brian has worked in the genomics space since 2012 and has a MS in Biochemistry and Molecular Biology from Georgetown University.
- Key Point: Health Professional Radio · QIAGEN – More Than Three Billion Biological Samples Tested
Brian Dugan is the Senior Director, Head of Enterprise Genomics and NGS Product Management at QIAGEN. Since joining QIAGEN, has lead commercialization of genomics solutions across application areas and modalities . These developments span ultra-sensitive targeted methylation chemistry for liquid biopsy testing, single-cell RNA detection solutions, microbiology and infectious disease testing, and market-leading miRNA NGS solutions. Brian has worked in the genomics space since 2012 and has a MS in Biochemistry and Molecular Biology from Georgetown University.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


